Diversified Healthcare Trust $DHC Shares Sold by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC decreased its holdings in shares of Diversified Healthcare Trust (NASDAQ:DHC) by 23.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 40,510 shares of the real estate investment trust’s stock after selling 12,199 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Diversified Healthcare Trust were worth $145,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Teacher Retirement System of Texas bought a new stake in Diversified Healthcare Trust in the first quarter valued at $59,000. Allianz Asset Management GmbH bought a new stake in Diversified Healthcare Trust in the first quarter valued at $298,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Diversified Healthcare Trust by 49.3% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 62,565 shares of the real estate investment trust’s stock valued at $150,000 after buying an additional 20,666 shares during the last quarter. Chicago Partners Investment Group LLC bought a new stake in Diversified Healthcare Trust in the first quarter valued at $34,000. Finally, Deutsche Bank AG lifted its stake in Diversified Healthcare Trust by 11.7% in the first quarter. Deutsche Bank AG now owns 233,202 shares of the real estate investment trust’s stock valued at $560,000 after buying an additional 24,510 shares during the last quarter. Institutional investors and hedge funds own 75.98% of the company’s stock.

Analysts Set New Price Targets

DHC has been the topic of several analyst reports. B. Riley raised their price target on shares of Diversified Healthcare Trust from $4.50 to $5.50 and gave the company a “buy” rating in a research note on Wednesday, September 17th. Weiss Ratings restated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $5.50.

Diversified Healthcare Trust Price Performance

NASDAQ DHC opened at $4.20 on Wednesday. Diversified Healthcare Trust has a 12 month low of $2.00 and a 12 month high of $4.65. The company has a debt-to-equity ratio of 1.42, a current ratio of 6.35 and a quick ratio of 6.35. The firm has a market capitalization of $1.01 billion, a PE ratio of -3.53 and a beta of 2.65. The company’s 50 day simple moving average is $4.23 and its 200 day simple moving average is $3.61.

Diversified Healthcare Trust (NASDAQ:DHC) last posted its quarterly earnings data on Monday, June 2nd. The real estate investment trust reported $0.01 EPS for the quarter. Diversified Healthcare Trust had a negative net margin of 18.83% and a negative return on equity of 14.69%. The business had revenue of $370.78 million for the quarter.

Diversified Healthcare Trust Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 13th. Investors of record on Monday, October 27th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Monday, October 27th. Diversified Healthcare Trust’s payout ratio is presently -3.36%.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.